Erste Group analyst Hans Engel upgrades Charles Schwab (NYSE:SCHW) from Hold to Buy.
B of A Securities Downgrades Organon to Underperform, Lowers Price Target to $25
B of A Securities analyst Jason Gerberry downgrades Organon (NYSE:OGN) from Neutral to Underperform and lowers the price target from $37 to $25.